Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Cox Energy discloses MXN 8.59 billion price for Cox Asset México acquisition

Cox Energy discloses MXN 8.59 billion price for Cox Asset México acquisition

BitgetBitget2026/10/15 20:19
  • Cox de México acquired Cox Asset México indirectly from parent Cox Infrastructure under a June 19, 2026 agreement for USD 500 million.
  • The acquisition brings 16 operating power plants with 2,601 MW of installed capacity into the group.
  • A parallel sale transferred international subsidiaries to Cox Infrastructure for MXN 1.34 billion, focusing the business on Mexico.
  • Cox Infrastructure subscribed for 124,486,772 shares through debt capitalization effective June 30, 2026, at MXN 35.58 per share.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Cox Energy SAB de CV published the original content used to generate this news brief on October 15, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss